Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Review Series

Cystic fibrosis

Series edited by James M. Wilson

This series summarizes the current knowledge of the molecular basis for cystic fibrosis and reviews the state of gene therapeutic and pharmacological strategies for therapeutic intervention.

Articles in series

The innate immune system in cystic fibrosis lung disease
Robert Bals, … , Daniel J. Weiner, James M. Wilson
Robert Bals, … , Daniel J. Weiner, James M. Wilson
Published February 1, 1999
Citation Information: J Clin Invest. 1999;103(3):303-307. https://doi.org/10.1172/JCI6277.
View: Text | PDF

The innate immune system in cystic fibrosis lung disease

  • Text
  • PDF
Abstract

Authors

Robert Bals, Daniel J. Weiner, James M. Wilson

×

The genesis of cystic fibrosis lung disease
Jeffrey J. Wine
Jeffrey J. Wine
Published February 1, 1999
Citation Information: J Clin Invest. 1999;103(3):309-312. https://doi.org/10.1172/JCI6222.
View: Text | PDF

The genesis of cystic fibrosis lung disease

  • Text
  • PDF
Abstract

Authors

Jeffrey J. Wine

×

Status of gene therapy for cystic fibrosis lung disease
Richard C. Boucher
Richard C. Boucher
Published February 15, 1999
Citation Information: J Clin Invest. 1999;103(4):441-445. https://doi.org/10.1172/JCI6330.
View: Text | PDF

Status of gene therapy for cystic fibrosis lung disease

  • Text
  • PDF
Abstract

Authors

Richard C. Boucher

×

Novel pharmacologic therapies for cystic fibrosis
Pamela L. Zeitlin
Pamela L. Zeitlin
Published February 15, 1999
Citation Information: J Clin Invest. 1999;103(4):447-452. https://doi.org/10.1172/JCI6346.
View: Text | PDF

Novel pharmacologic therapies for cystic fibrosis

  • Text
  • PDF
Abstract

Authors

Pamela L. Zeitlin

×

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts